1.
J Eur Acad Dermatol Venereol
; 36(9): e669-e672, 2022 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35536636
2.
Clin Exp Dermatol
; 47(1): 161-163, 2022 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34291477
RESUMO
Evidence is accumulating that COVID-19 vaccines might induce or exacerbate autoimmune rheumatic diseases. The currently available COVID-19 vaccines include mRNA and recombinant adenoviral vector vaccines, both encoding SARS-CoV-2 spike protein production as the primary target for neutralizing antibodies. We report a case of subacute cutaneous lupus erythematosus (SCLE) following mRNA vaccination with the Pfizer mRNA vaccine BNT162b2, and summarize the current literature on CLE occurring after COVID-19 vaccination.
Assuntos
Vacina BNT162/efeitos adversos , COVID-19/prevenção & controle , Toxidermias/etiologia , Lúpus Eritematoso Cutâneo/induzido quimicamente , Ad26COVS1/efeitos adversos , Idoso , ChAdOx1 nCoV-19/efeitos adversos , Humanos , Masculino , SARS-CoV-2 , Vacinação/efeitos adversos
3.
J Eur Acad Dermatol Venereol
; 35(11): e733-e735, 2021 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34243220